Media Pack
News

Current Edition

Volume 16 Issue 1
 
Volume 15 Issue 4

FDA Focus on the Safety of Gene Therapy Products

Within the past 6 years, the US Food and Drug Administration (FDA) has approved a growing number of cellular and gene therapy products to treat a variety of conditio...
24 January 2024 Volume 15 Issue 4 Drug Administration | Dystrophy
Continue Reading →
Volume 15 Issue 4

Precision Medicine: Targeted Therapy in Paediatric Oncology Patients

For several decades, cancer has been one most of the devastating diseases affecting paediatric patients. A huge number of clinical trials and research papers are aim...
24 January 2024 Volume 15 Issue 4 cancer | devastating
Continue Reading →
Volume 15 Issue 2

Exploring the Limb Girdle Muscular Dystrophy Clinical Trial Landscape

With the recent advent of adeno-associated, virus-based gene therapy treatments, limb-girdle muscular dystrophy (LGMD) is currently attracting the attention of the b...
6 July 2023 Volume 15 Issue 2 adeno-associated | clinical
Continue Reading →
Regional News

Gilead’s Kite flies higher as Yescarta leads CAR-T therapy class to earlier lymphoma treatment

Existing CAR-T therapies have been saved for blood cancer patients who’ve tried multiple treatments—until now. With a first-in-class nod, the FDA has cleared Yesc...
4 April 2022 Regional News CAR T | Gilead
Continue Reading →
Regional News

Antares, Lipocine expand testosterone therapy offerings with FDA nod for a new, oral med for hypogonadism

In 2018 with Xyosted, Antares brought to the market a user-friendly testosterone replacement therapy for hypogonadism, with the drug administered at home by weekly in...
30 March 2022 Regional News Antares | FDA
Continue Reading →
Regional News

Bayer leads $80M funding round for Cellino, betting on new cell therapy manufacturing platform

Since it was established in 2017, Cellino Biotech has offered an intriguing approach to stem cell therapy manufacturing, combining biology, laser physics, gene editin...
26 January 2022 Regional News Bayer | cell
Continue Reading →
Regional News

ASH: Senti Bio’s gene circuit CAR-NK cell therapy enhances cancer killing and safety in leukemia models

Engineered cell therapy has revolutionized the treatment of blood cancers, but precisely selecting the right target to kill off cancer cells while sparing healthy cel...
10 December 2021 Regional News cancer | CAR-NK
Continue Reading →
Europe

Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull ...
16 May 2018 Europe bolster | cell
Continue Reading →
news

Tianhe Life Sciences leads $9.5m Series A in Clover Biopharma

Tianhe Life Sciences leads $9.5m Series A in Clover Biopharma Clover is utilising its proprietary Trimer-Tag technology platform to develop biologics targeting trimer...
20 December 2017 news biologics | clinical development
Continue Reading →
news

CRISPR Therapeutics Announces Planned European Clinical Trial

CRISPR Therapeutics today announced the submission of a Clinical Trial Application (CTA) today for CTX001 in β-thalassemia. CTX001 is an investigational CRISPR gene-e...
13 December 2017 news application | clinical trial
Continue Reading →
 
 

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2024, All Rights Reserved – Powered by Teksyte